newsfilter
← Latest News
Business Wire·

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference

Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today